Okt 22, 2012 | Allgemein, company news @en, DE
The medical technology company Aesculap has increased its sales in the first nine months of this year by 6.3 percent to EUR 1.05 billion. A downside, however, was that they had lower sales in Europe, where 65 percent of total revenues were generated. As health...
Okt 22, 2012 | Allgemein, company news @en, DE
The Swiss pharmaceutical company Roche grew stronger than the German pharmaceutical market in the first nine months in Germany because of the strong demand for cancer drugs. The total turnover of the world’s leading manufacturer of drugs to treat cancer...
Okt 22, 2012 | Allgemein, company news @en, DE
The pharmaceutical and medical device company Baxter International Inc. has reported a net profit of $583 million for the third quarter. In the previous year this was $576 million (+1.2 percent). Revenue for the quarter was unchanged at $3.48 billion. In the coming...
Okt 19, 2012 | Allgemein, company news @en, DE, market knowledge, medical technology, new business
About 60% of Germans now regularly wear glasses to correct their vision problem. Since 2004 glasses, however, no longer come under the remit of statutory health insurance. The rationale for this decision is that a refractive error is not considered disease. Only in...
Okt 19, 2012 | Allgemein, company news @en, DE
The world’s biggest food group Nestle has compensated for the decline in demand from debt-crisis-plagued industrial countries by recording strong growth in emerging markets. In a statement by the Group, the sales in the first nine months of 2012 compared to the...
Okt 19, 2012 | Allgemein, company news @en, DE
The Swiss biotech company Actelion (Allschwil) increased its profit in the third quarter despite restructuring costs. The company of Europe’s largest independent industry increased profits by 16 percent to 94.6 million Swiss francs. Excluding special items, the...